Virus contaminations of cell cultures - A biotechnological view

Cytotechnology

Volumn 39, Issue 2, 2002, Pages 91-116

  Merten, O W ^a  

^a GÉNÉTHON   (France)

Author keywords

Animal cell culture; CHO; Continuous cell lines; Hybridoma; Prevention; Primary cells; Raw materials; Risks; Viral contaminants

Indexed keywords

VIRUS VACCINE;

ADENOVIRUS; BIOTECHNOLOGY; CELL CULTURE; CELL STRUCTURE; CONFERENCE PAPER; CYTOPATHOGENIC EFFECT; EVIDENCE BASED MEDICINE; FUNCTIONAL ASSESSMENT; HERPES SIMPLEX VIRUS; HUMAN; INDUSTRY; LABORATORY; MATERIAL STATE; MEASLES VIRUS; MEASUREMENT; MEDICAL RESEARCH; MICROSCOPY; NONHUMAN; POLIOMYELITIS VIRUS; PROVIRUS; RISK FACTOR; ROTAVIRUS; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS GENOME;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; HERPES; MEASLES VIRUS; MYCOPLASMA; POLIOVIRUS; ROTAVIRUS; SIMPLEXVIRUS;

EID: 0037545957     PISSN: 09209069     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022969101804     Document Type: Conference Paper

References (109)

1. Adamson SR (1998) Experiences of virus, retrovirus and retroviruslike particles in chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics. Dev Biol Standard 93: 89-96.
2. Anderson KP, Lie YS, Low M-AL, Williams SR, Fennie EH, Nguyen TP and Wurm FM (1990) Presence and transcription of intracisternal A-particle related sequences in CHO cells. J Virol 64: 2021-2032.
3. Aranha-Creado H, Oshima K, Jafari S, Howard Jr G and Brandwein H (1997) Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter. PDA J Pharm Sci Technol 51: 119-124.
4. Berns KI, Pinkerton TC, Thomas GF and Hoggan MD (1975) Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556-560.
5. Berthold W, Werz W and Walter JK (1996) Relationship between nature and source of risk and process validation. Dev Biol Standard 88: 59-71.
6. Bhatt PN, Jacoby RO and Barthold SW (1986) Contamination of transplanatble murine tumors with lymphocytic choriomeningitis virus. Lab Anim Sci 36: 136-139.
7. Biagini P, Gallian P, Touinssi M, Cantaloube JF, Zapitelli J, De Lamballerie X and De Micco P (2000) High prevalence of TT virus infection in French blood donors revealed by the use of three PCR systems. Transfusion 40: 590-595.
8. Bolin SR, Matthews PJ and Ridpath JF (1991) Methods for detection and frequency of contamination of fetal calf serum with bovine viral diaahea virus and antibodies against bovine viral diarrhea virus. J Vet Diagn Invest 3: 199-203.
9. Bolin SR, Ridpath JF, Black J, Macy M and Roblin R (1994) Survey of cell lines in the American Type Culture Collection for bovine viral diarrhea virus. J Virol Meth 48: 211-221.
10. Brands R, Visser J, Medema J, Palache AM and Van Scharrenburg GJM (1999) InfluvacTC: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. Dev Biol Standard 98: 93-100.
11. Brown F, Meyer RF, Law M, Kramer E and Newman JFE (1999) A universal virus inactivant for decontaminating blood and biopharmaceutical products. Dev Biol Standard 99: 119-130.
12. Buller RML, Weinblatt AC, Hamburger AW and Wallace GD (1987) Observations on the replication of ectromelia virus in mouse derived cell lines: Implications for emidemiology of mousepox. Lab Anim Sci 37: 28-32.
13. Burstyn DG (1996) Contamination of genetically engineered chinese hamster ovary cells. Dev Biol Standard 88: 199-203.
14. Butler M (1991) The characteristics and growth of cultured cells. In: M Butler (ed.), 'Mammalian Cell Biotechnology - A Practical Approach', (pp. 1-25), IRL Press/Oxford University Press, Oxford, U.K.
15. Cartwright T (1994) Animal Cells as Bioreactors. Cambridge Studies in Biotechnology, Vol. 11, Cambridge University Press, Cambridge, U.K.
16. Collins Jr MJ and Parker JC (1972) Murine virus contaminants of leukemia viruses and transplantable tumors. J Natl Cancer Inst 49: 1139-1143.
17. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines. EEC Regulatory Document. Note for Guidance (1992). Guidelines for medicinal products derived from human blood and plasma. Biologicals 20: 159-164.
18. CPMP (2002) Note for guidance on the use of bovine serum in the manufacture of human biological medicinal products. EMEA, 25 April 2002, CPMP/BWP/1793/02.
19. Crawford DH, Achong BG, Teich NM, Finerty S, Thompson JL, Epstein MA and Giovanella BC (1979) Identification of murine endogenous xenotropic retrovirus in cultured multicellular tumour spheroids from nude-mouse-passaged nasopharyngeal carcinoma. Int J Cancer 23: 1-7.
20. Croghan DL, Matchett A and Koski TA (1973) Isolation of porcine parvovirus from commercial trypsin. Appl Microbiol 26: 431-433.
21. Dinowitz M, Lie YS, Low M-AL, Lazar R, Fautz C, Potts B, Sernatinger J and Anderson K (1992) Recent studies on retrovirus-like particles in chinese hamster ovary cells. Dev Biol Standard 76: 201-207.
22. Eddy BE, Borman GS, Berkeley WH and Young RD (1961) Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med 197: 191-197.
23. Ellis JA, Konoby C, West KH, Allan GM, Krakowka S, McNeilly F, Meehan B and Walker I (2001) Lack of antibodies to porcine circovirus type 2 virus in beef and dairy cattle and horses in western Canada. Can Vet J 42: 461-464.
24. Eloit M (1997) Risques virologiques associés aux matières premières extraites de tissus animaux utilisés dans la fabrication des médicaments. Virologie 1: 413-422.
25. Eloit M (1999) Risks of virus transmission associated with animal sera or substitutes and methods of control. Dev Biol Standard 99: 9-16.
26. Enders JF, Weller TH and Robbins FC (1949) Cultivation of Lansing strain of poliomyelitis virus in culture of various human embryonic tissues. Science 109: 85-87.
27. Erickson GA, Landgraf JG, Wessman SJ, Koski TA, Moss LM (1989) Detection and elimination of adventitious agents in continuous cell lines. Dev Biol Standard 70: 59-66.
28. Falcone E, Tollis M and Conti G (2000) Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 18: 387-388.
29. Fikrig MK and Tattersall P (1992) Latent parvoviral infection of continuous cell lines. Dev Biol Standard 76: 285-293.
30. French GR, Foulke RS, Brand OD, Addy GA, Lee HW and Lee PW (1981) Korean haemorrhagic fever. Propagation of the etiologic agent in a cell line of human origin. Science 211: 1046-1048.
31. Fritsch E (1992) Validation of virus removal in large scale purification processes. Dev Biol Standard 76: 239-248.
32. Froud SJ, Birch J, McLean C, Shepherd AJ and Smith KT (1997) Viral contaminants found in mouse cell lines used in the production of biological products. In: MJT Carrondo et al. (eds), 'Animal Cell Technology', (pp. 681-686), Kluwer Academic Publishers, Dordrecht, The Netherlands.
33. Garnick RL (1996) Experience with viral contamination in cell culture. Dev Biol Standard 88: 49-56.
34. Graf E-G, Jander E, West A, Pora H and Aranha-Creado, H (1999) Virus removal by filtration. Dev Biol Standard 99: 89-94.
35. Hallauer C and Kronauer G (1960) Nachweis von Gelbfiebervirus Haemagglutinin in Menschlichen Explantaten. Arch ges Virusf 10: 267-287.
36. Hallauer C, Kronauer G and Siegl G (1971) Parvoviruses as contaminants of permanent human cell lines. I. Virus isolations from 1960-1970. Arch ges Virusf 35: 80-90.
37. Hansen G and Foster L (1997) Viral safety in serum for cell culture use. Art to Science 16: 1-7.
38. Harasawa R (1995) Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases. Vaccine 13: 100-103.
39. Harasawa R and Mizusawa H (1995) Demonstration and genotyping of pestivirus RNA from mammalian cell lines. Microbiol Immunol 39: 979-985.
40. Harasawa R and Sasaki T (1995) Sequence analysis of the 5' untranslated region of pestivirus RNA demonstrated in interferons for human use. Biologicals 23: 263-269.
41. Hay RJ (1991) Operator-induced contamination in cell culture systems. Dev Biol Standard 75: 193-204.
42. Hoggan MD (1970) Adenovirus associated virus. Progr Med Virol 12: 211-239.
43. Hoggan MD, Thomas GF and Johnson FB (1972) Continuous 'carriage' of adenovirus-associated virus genome in cell culture in the absence of helper adenovirus. In: 'The Proceedings of the 4th Lepetit Colloquium' (pp. 243-249), North Holland Publishing, Amsterdam, The Netherlands.
44. Horaud F (1997) La sécurité virale des produits biologiques: Aspects historiques et conceptuels. Virologie 1: 365-372.
45. Hughes B (1996) Key points from Nettleton and Rweyemamu (1980): Association of calf serum with parvovirus infection.
46. ICH Topic Q5A (1997) Quality of Biotechnological Products: Viral safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. Note for guidance CPMP/ICH/295/95, http://www.eudra.org/emea.html/.
47. Jayme DW (1999) An animal origin perspective of common constituents of serum-free medium formulations. Dev Biol Standard 99: 181-187.
48. Johnston A, MacGregor A, Borovec S, Hattarki M, Stuckly K, Anderson D, Goss NH, Oates A and Uren E (2000) Inactivation and clearance of viruses during the manufacture of high purity Factor IX. Biologicals 28: 129-136.
49. Kappler A, Lutz-Wallace C, Sapp T and Sidhu M (1996) Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polemerase chain reaction. Biologicals 24: 131-135.
50. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Eder G and Dorner F (1999) Development of a Vero cell derived influenza whole virus vaccine. Dev Biol Standard 98: 101-110.
51. Klein G, Dombos, L and Gathoskar B (1972) Sensitivity of Epstein-Barr virus producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer 10: 44-57.
52. Kniazeff AJ (1973) Endogenous virus contaminants in fetal bovine serum and their role in tissue culture contamination. In: J Fogh (ed.), Contamination in Tissue Culture (pp. 233-242), Academic Press, New York.
53. Kreeft HAJG, Greiser-Wilke I, Moenning V and Horzinek MC (1990) Attempts to characterize bovine viral diarrhea virus isolated from cattle after immunization with a contaminated vaccine. Dtsch Tieräztl Wschr 97: 63-65.
54. Kuff EL and Lueders KK (1988) The intracisternal A-particle gene family; structure and functional aspects. Adv Cancer Res 51: 183-276.
55. Kurth J, Waldmann R, Heith J, Mausbach K and Burian R (1999) Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation. Dev Biol Standard 99: 111-118.
56. Larzul D (1999) Viral validation design of a manufacturing process. Dev Biol Standard 99: 139-150.
57. LeDuc JW, Smith GA, Macy M and Hay RJ (1985) Certified cell lines of rat origin free of infection with Hantavirus. J Infect Dis 1522: 1082-1083.
58. Leiter EH, Malinoski FJ and Eppig JJ (1978) An epithelial cell line with chronic polyoma infection established from a spontaneous mouse pancreatic adenocarcinoma. Cancer Res 38: 969-977.
59. Levy JA (1983) Mouse plasmacytoma cells produce infectious type C viruses. The Lancet ii: 522.
60. Lloyd G and Jones N (1986) Infection of laboratory workers with hantavirus acquired from immunocytomas propagated in laboratory rats. J Infect 12: 117-125.
61. Lubiniecky AS and Shadle PJ (1997) Raw material considerations. Dev Biol Standard 91: 65-72.
62. Magrath DI (1991) Safety of vaccines produced in continuous cell lines. Dev Biol Standard 75: 17-20.
63. Mahy BWJ, Dykewicz C, Fisher-Hoch S, Ostroff S, Tipple M and Sanchez A (1991) Virus zoonosis and their potential for contamination of cell culture. Dev Biol Standard 75: 183-189.
64. Makoschey B, Patel JR and Van Gelder PTJA (2002) Serum-free produced bovine herpesvirus type 1 and bovine parainfluenza type 3 virus vaccines are efficacious and safe. Cytotechnology (in press).
65. Mareschal J-C (1999) Quality control of bovine serum used for vaccine production. Dev Biol Standard 99: 61-68.
66. Mayor HD and Melnick JL (1966) Small deoxyribonucleic acid-containing viruses (Picodnavirus group). Nature 210: 331-332.
67. Mayor HD, Ito M, Jordan LE and Melnick JL (1967) Morphological studies on the replication of a defective satellite virus and its helper adenovirus. J Natl Cancer Inst 38: 805-820.
68. McCormick JG, Sasso DR, Palmer EL and Kiley MP (1982) Morphological identification of the agent of Korean haemorrhagic fever (Hantaan virus) as a member of the Bunyaviridae. The Lancet i: 765-768.
69. Merten O-W (1999) Safety issues of animal products used in serum-free media. Dev Biol Standard 99: 167-180.
70. Minor PD (1996) Mammalian cells and their contaminants. Dev Biol Standard 88: 25-29.
71. Moore WA (1992) Experience in cell line testing. Dev Biol Standard 76: 51-56.
72. Nakai N, Kawaguchi C, Nawa K, Kobayashi S, Katsuta Y and Watanabe M (2000) Detection and elimination of contaminating microorganisms in transplantable tumors and cell lines. Exp Anim 49: 309-313.
73. Nettleton PF and Rweyemamu MM (1980) The association of calf serum with the contamination of BHK 21 clone 13 suspension cells by a parvovirus serologically related to the Minute Virus of Mice (MVM). Arch Virol 64: 359-374.
74. Nicklas W, Kraft V and Meyer B (1993) Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab Anim Sci 43: 296-299.
75. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y and Mayumi M (1997) A noveal DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92-97.
76. O'Connor B, Gauvreau H, West K, Bogdan J, Ayroud M, Clark EG, Konoby C, allan G and Ellis JA (2001) Multiple porcine circovirus 2-associated abortions and reproductive failure in a multisite swine production unit. Can Vet J 42: 551-553.
77. Peters CJ, Jahrling, PB, Ksiazek TG, Johnson ED and Lupton HW (1992) Filovirus contamination of cell cultures. Dev Biol Standard 76: 267-274.
78. Plavsic MZ, Daley JP, Danner DJ and Weppner DJ (1999) Gamma irradiation of bovine sera. Dev Biol Standard 99: 95-109.
79. Poiley JA (1990) Methods for the detection of adventitious viruses in cell cultures used in the production of biotechnology products. Bioprocess Tech 10: 483-494.
80. Rabenau H, Ohlinger V, Anderson J, Selb B, Cinatl J, Wolf W, Frost J, Mellor P and Doerr HW (1993) Contamination of genetically engineered CHO-cells by epizootic haemorrhagic disease virus (EHDV). Biologicals 21: 207-214.
81. Robertson JS (1996) Strategy for adventitious agent assays. Dev Biol Standard 88: 37-40.
82. Roehe PM and Edwards S (1994) Comparison of pestivirus multiplication in cells of different species. Res Vet Sci 57: 210-214.
83. Schuurman R, Van Steenis B and Sol C (1991) Review. Bovine polyomavirus, a frequent contaminant of calf serum. Biologicals 19: 265-270.
84. Sanchez Jr RE, Nauwynck HHJ, McNeilly F, Allan GM and Pensaert (2001) Porcine circovirus 2 infection in swine foetuses inoculated at different stages of getation. Vet Microbiol 83: 169-176.
85. Schuurman R, Van Steenis B, Van Strieben A, Van der Noordaa J and Sol C (1991) Frequent detection of bovine polyomavirus (BPyV) in commercial batches of calf serum, using the polymerase chain reaction. J Gen Virol 72: 2739-2745.
86. Schweizer H, Sprössig M, Mücke H and Wutzler P (1972) Peracetic acid as sterilizing agent for culture serum. Nature New Biology 240: 61-62.
87. Shah K and Nathanson N (1976) Human exposure to SV40: review and comment. Am J Epidemiol 103: 1-12.
88. Shah KV, Willard S, Myers RE, Hess DM and DiGiacomo R (1969) Experimental infection of rhesus with Simian Virus 40 (SV40). Proc Soc Exp Biol Med 130: 196-203.
89. Smith CEG, Simpson DIH, Bowen ETW and Zlotnik I (1967) Fatal human disease from Vervet monkeys. The Lancet ii: 1119-1121.
90. Spriggs DR and Krueger RG (1979) Identification of the major structural proteins of two BALB/c myeloma C-type viruses. Virology 98, 35-44.
91. Sprössig M and Mücke H (1967) Über die antimikrobielle Wirkung der Peressigsäure. 5. Mitteilung: Untersuchung zur viruziden Wirkung. Pharmazie 23: 665-667.
92. Stones PB (1977) Production and control of live oral poliovirus vaccine in WI-38 human diploid cells. Dev Biol Standard 37: 251-253.
93. 40. Proc Soc Exp Biol Med 105: 420-427.
94. Tischer I, Gelderblom H, Vettermann W and Kock MA (1982) A very small porcine virus with circular single-stranded DNA. Nature 295: 64-66.
95. Troccoli NM, McIver J, Losikoff A and Poiley J (1998) Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration. Biologicals 26: 321-329.
96. Van der Noordaa, Sol CJA and Schuurman R (1999) Bovine polyomavirus, a frequent contaminant of calf sera. Dev Biol Standard 99: 45-47.
97. Vannier P, Leforban Y, Carnero R and Cariolet R (1988) Contamination of a live virus vaccine against pseudorabies (Aujeszky's Disease) by an ovine pestivirus pathogen for the pig. Ann Rech Vét 19: 283-290.
98. Van Steenis G, Van Wezel AL, De Groot IGM and Kruijt BC (1980) Use of captive-bred monkeys for vaccine production. Dev Biol Standard 45: 99-105.
99. Van Wezel AL, Van der Velden-de Groot CAM and Van Herwaarden JAM (1980) The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys. Dev Biol Standard 46: 151-158.
100. Van Wezel AL, Van Steenis G, Hannik ChA and Cohen H (1978) New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Standard 41: 159-168.
101. Waldeck W and Sauer G (1977) New oncogenic papovavirus from primate cells. Nature (London) 269: 171-173.
102. Weiss RA (1982) Retroviruses produced by hybridomas. New Engl J Med 307: 1587.
103. Werz W, Hoffmann H, Haberer K and Walter JK (1997) Strategies to avoid virus transmissions by biopharmaceutic products. Arch Virol S13, 245-256.
104. Wessman SJ and Levings RL (1999) Benefits and risks due to animal serum used in cell culture production. Dev Biol Standard 99: 3-8.
105. Wilbur LA, Evermann JF, Levings RL, Stoll IR, Starling DE, Spillers CA, Gustafson GA and McKeiman AJ (1994) Abortion and death in pregnant bitches associated with a canine vaccine contaminated with bluetongue virus. JAVMA 204: 1762-1765.
106. Willkommen H, Scheiblauer H and Löwer J (1999) Serum and serum substitutes: Virus safety by inactivation or removal. Dev Biol Standard 99: 131-138.
107. Wognum AW, Sol CJA, Van der Noordaa J, Van Steenis G and Osterhaus ADME (1984) Isolation and characterization of a papovavirus from cynomolgus macaque kidney cells. Virology 134: 254-257.
108. Yanagi M, Bukh J, Emerson and Purcell RH (1996) Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: Implications for the study of hepatitis C cirus in cell cultures. J Infect Dis 174: 1324-1327.
109. Yuasa N, Taniguchi T and Yoshida I (1979) Isolation and characteristics of an agent inducing anemia in chicks. Avian Dis 23: 366-385.